Cefadroxil

Product NDC: 21695-427
11-digit product format: 216950427
Labeler code: 21695
Product ID: 21695-427_b757af04-e516-4ac7-8a2f-45fffab86c5d
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Cefadroxil
Dosage form: CAPSULE
Route: ORAL
Labeler: Rebel Distributors Corp
Application: ANDA065311
Marketing category: ANDA
Marketing start: 2006-02-07
Marketing end: 0000-00-00
Substance: CEFADROXIL
Active strength: 500 mg/1
NDC exclude flag: E
Listing certified through: 2017-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 5 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	21695-427		I	Inactivated by FDA	2026-08-03
excluded package	package	21695-427	21695-427-10	I	Inactivated by FDA	2026-08-03
excluded package	package	21695-427	21695-427-20	I	Inactivated by FDA	2026-08-03
excluded package	package	21695-427	21695-427-28	I	Inactivated by FDA	2026-08-03
excluded package	package	21695-427	21695-427-50	I	Inactivated by FDA	2026-08-03

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 2 · 110 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	21695-427-20	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	21695-427-28	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	21695-427-10	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	21695-427-50	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	21695-427-20	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	21695-427-28	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	21695-427-10	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	21695-427-50	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	21695-427-20	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	21695-427-28	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	21695-427-10	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	21695-427-50	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	21695-427-20	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	21695-427-28	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	21695-427-10	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	21695-427-50	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	21695-427-20	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	21695-427-28	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	21695-427-10	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	21695-427-50	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	21695-427-20	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	21695-427-28	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	21695-427-10	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	21695-427-50	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	21695-427-20	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	21695-427-28	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	21695-427-10	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	21695-427-50	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	21695-427-20	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	21695-427-28	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	21695-427-10	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	21695-427-50	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	21695-427-20	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	21695-427-28	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	21695-427-10	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	21695-427-50	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	21695-427-20	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	21695-427-28	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	21695-427-10	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	21695-427-50	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	21695-427-20	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	21695-427-28	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	21695-427-10	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	21695-427-50	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	21695-427-20	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	21695-427-28	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	21695-427-10	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	21695-427-50	`557ba5c1ecfa…`	`9c80585c8c6e…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A065311-001	CEFADROXIL	CEFADROXIL/CEFADROXIL HEMIHYDRATE	EQ 500MG BASE	CAPSULE / ORAL			2006-02-07

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A065311-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL		2006-02-07	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A065311-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL		2006-02-07	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A065311-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL		2006-02-07	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A065311-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL		2006-02-07	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A065311-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL		2006-02-07	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A065311-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL		2006-02-07	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A065311-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL		2006-02-07	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A065311-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL		2006-02-07	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A065311-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL		2006-02-07	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A065311-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL		2006-02-07	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A065311-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL		2006-02-07	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A065311-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL		2006-02-07	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A065311-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL		2006-02-07	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A065311-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL		2006-02-07	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A065311-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL	AB	2006-02-07	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A065311-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL	AB	2006-02-07	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A065311-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL	AB	2006-02-07	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A065311-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL	AB	2006-02-07	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A065311-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL	AB	2006-02-07	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A065311-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL	AB	2006-02-07	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A065311-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL	AB	2006-02-07	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A065311-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL	AB	2006-02-07	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A065311-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL	AB	2006-02-07	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A065311-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL	AB	2006-02-07	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A065311-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL	AB	2006-02-07	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A065311-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL	AB	2006-02-07	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A065311-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL	AB	2006-02-07	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A065311-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL		2006-02-07	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A065311-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL		2006-02-07	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A065311-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL	AB	2006-02-07	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A065311-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL	AB	2006-02-07	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A065311-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL	AB	2006-02-07	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A065311-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL	AB	2006-02-07	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A065311-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL	AB	2006-02-07	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A065311-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL	AB	2006-02-07	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A065311-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL	AB	2006-02-07	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A065311-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL	AB	2006-02-07	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A065311-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL	AB	2006-02-07	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	A065311-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL	AB	2006-02-07	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	A065311-001	CEFADROXIL	EQ 500MG BASE	CAPSULE / ORAL	AB	2006-02-07	`cb3db0bc1861…`

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A065311-001	AB	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A065311-001	AB	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A065311-001	AB	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A065311-001	AB	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A065311-001	AB	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A065311-001	AB	1	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A065311-001	AB	1	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A065311-001	AB	1	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A065311-001	AB	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A065311-001	AB	1	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A065311-001	AB	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A065311-001	AB	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A065311-001	AB	1	`ea99ee380514…`
2023-12-20 04:57 UTC	2023-12	A065311-001	AB	1	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A065311-001	AB	1	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A065311-001	AB	1	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A065311-001	AB	1	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A065311-001	AB	1	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A065311-001	AB	1	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A065311-001	AB	1	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A065311-001	AB	1	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A065311-001	AB	1	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	A065311-001	AB	1	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	A065311-001	AB	1	`cb3db0bc1861…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
560bed03-0257-a1db-0638-2c46fc35054c	Product name	2	20170824
34f1b9ee-0673-df8c-ddae-36eaf4c48382	Product name	1	20140508
3793572a-4958-68b2-f923-8cf695ec1cc1	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Related label table
NDC	Related label
21695-427-10	CEFADROXIL CAPSULES USP CEFADROXIL TABLETS USP
21695-427-20	CEFADROXIL CAPSULES USP CEFADROXIL TABLETS USP
21695-427-28	CEFADROXIL CAPSULES USP CEFADROXIL TABLETS USP
21695-427-50	CEFADROXIL CAPSULES USP CEFADROXIL TABLETS USP

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
21695-427-10	Cefadroxil	10 in 1 BOTTLE	CAPSULE	10	1
21695-427-20	Cefadroxil	20 in 1 BOTTLE	CAPSULE	20	1
21695-427-28	Cefadroxil	28 in 1 BOTTLE	CAPSULE	28	1
21695-427-50	Cefadroxil	50 in 1 BOTTLE	CAPSULE	50	1

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
21695-427-10	EA - Each	21695-427	62b32ad6-baa1-4296-b346-5c09753f85ef	1	2013-02-13
21695-427-20	EA - Each	21695-427	703d3b4c-1f1f-4a48-80d8-cde94739ce3e	1	2013-02-13
21695-427-28	EA - Each	21695-427	c7367914-6efd-4156-814e-b672233c59b3	1	2013-02-13
21695-427-50	EA - Each	21695-427	4ab800f3-4be8-4203-bc78-a6af71d61ab3	1	2013-02-13

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
CEFADROXIL	ACTIVE INGREDIENT	280111G160	CEFADROXIL CAPSULE [REBEL DISTRIBUTORS CORP]	1
CEFADROXIL	ACTIVE MOIETY	280111G160	CEFADROXIL CAPSULE [REBEL DISTRIBUTORS CORP]	1
COLLOIDAL SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	CEFADROXIL CAPSULE [REBEL DISTRIBUTORS CORP]	1
CROSCARMELLOSE SODIUM	INACTIVE INGREDIENT	M28OL1HH48	CEFADROXIL CAPSULE [REBEL DISTRIBUTORS CORP]	1
FERRIC OXIDE RED	INACTIVE INGREDIENT	1K09F3G675	CEFADROXIL CAPSULE [REBEL DISTRIBUTORS CORP]	1
FERROSOFERRIC OXIDE	INACTIVE INGREDIENT	XM0M87F357	CEFADROXIL CAPSULE [REBEL DISTRIBUTORS CORP]	1
GELATIN	INACTIVE INGREDIENT	2G86QN327L	CEFADROXIL CAPSULE [REBEL DISTRIBUTORS CORP]	1
LACTOSE MONOHYDRATE	INACTIVE INGREDIENT	EWQ57Q8I5X	CEFADROXIL CAPSULE [REBEL DISTRIBUTORS CORP]	1
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	CEFADROXIL CAPSULE [REBEL DISTRIBUTORS CORP]	1
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	CEFADROXIL CAPSULE [REBEL DISTRIBUTORS CORP]	1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
21695-427	CEFADROXIL CAPSULE [REBEL DISTRIBUTORS CORP]	1	Legacy NDC, 4 package rows	20110201_b757af04-e516-4ac7-8a2f-45fffab86c5d.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
280111G160	CEFADROXIL	66592-87-8	CEFADROXIL

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
309049	cefadroxil 500 MG Oral Capsule	PSN	b757af04-e516-4ac7-8a2f-45fffab86c5d	1
309049	cefadroxil 500 MG Oral Capsule	SCD	b757af04-e516-4ac7-8a2f-45fffab86c5d	1
309049	cefadroxil (as cefadroxil monohydrate) 500 MG Oral Capsule	SY	b757af04-e516-4ac7-8a2f-45fffab86c5d	1

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Status
21695-427-10	21695042710	10 in 1 BOTTLE	Historical
21695-427-20	21695042720	20 in 1 BOTTLE	Historical
21695-427-28	21695042728	28 in 1 BOTTLE	Historical
21695-427-50	21695042750	50 in 1 BOTTLE	Historical

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
CEFADROXIL CAPSULES USP CEFADROXIL TABLETS USP	Rebel Distributors Corp	2011-01-26	HUMAN PRESCRIPTION DRUG LABEL	1